<DOC>
	<DOCNO>NCT02315417</DOCNO>
	<brief_summary>The study evaluate efficacy safety gevokizumab treat active ulcer pyoderma gangrenosum ( PG ) .</brief_summary>
	<brief_title>An Efficacy Safety Study Gevokizumab Treating Active Ulcers Pyoderma Gangrenosum</brief_title>
	<detailed_description />
	<mesh_term>Pyoderma Gangrenosum</mesh_term>
	<mesh_term>Pyoderma</mesh_term>
	<criteria>A clinical diagnosis classic pyoderma gangrenosum An active pyoderma gangrenosum ulcer Contraceptive measure adequate prevent pregnancy study Clinical evidence acutely infected pyoderma gangrenosum History allergic anaphylactic reaction monoclonal antibody History recurrent chronic systemic infection Female subject pregnant , plan become pregnant , recently deliver , breastfeed Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Pyoderma Gangrenosum</keyword>
	<keyword>Classic Pyoderma Gangrenosum</keyword>
</DOC>